Drugs / vaccinia-CEA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003125 | Jan 1998 → Nov 2004 | breast cancer, esophageal cancer, gastric cancer, lung cancer +1 | Georgetown University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | vaccinia-CEA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003125 ↗ |
| Known as | vaccinia-carcinoembryonic antigen (CEA) vaccine | “vaccinia-carcinoembryonic antigen (CEA) vaccine intradermally on day 1” NCT00003125 ↗ |
| Modality | Vaccine | “vaccinia-CEA vaccine” NCT00003125 ↗ |
| Route | Intravenous | “vaccinia-carcinoembryonic antigen (CEA) vaccine intradermally on day 1” NCT00003125 ↗ |